University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Manganese complex [Mn(CO)₃(tpa-κ³N)]Br increases antibiotic sensitivity in multidrug resistant Streptococcus pneumoniae

Liakopoulos, Apostolos, La Ragione, Roberto M., Nagel, Christoph, Schatzschneider, Ulrich, Rozen, Daniel E. and Betts, Jonathan W. (2020) Manganese complex [Mn(CO)₃(tpa-κ³N)]Br increases antibiotic sensitivity in multidrug resistant Streptococcus pneumoniae Journal of Global Antimicrobial Resistance.

Manganese complex.pdf - Accepted version Manuscript
Available under License Creative Commons Attribution.

Download (1MB) | Preview



The emergence of multidrug-resistance (MDR) in Streptococcus pneumoniae clones and non-vaccine serotypes necessitate the development of novel treatment strategies. This work aimed to determine the efficacy of the Mn complex [Mn(CO)³(tpa-κ³N)]Br against clinically important MDR strains of S. pneumoniae.


Twenty MDR clinicalS. pneumoniae strains were included in this study. Minimum inhibitory concentrations (MICs) of [Mn(CO)₃(tpa-κ³N)]Br were determined via broth microdilution alone and in combination with other antimicrobial agents using checkerboard assays and/or disc diffusion tests. In vitro efficacy was assessed by time-kill assays while in vivo efficacy was tested using the insect model Galleria mellonella.


[Mn(CO)₃(tpa-κ³N)]Br showed moderate in vitro efficacy against S. pneumoniae coupled with bactericidal activity. Checkerboard and disc diffusion assays showed synergy between [Mn(CO)₃(tpa-κ³N)]Br and tetracycline, and the combination of both agents caused rapid kill-kinetics and reduced the MIC below the susceptibility breakpoint of 1 mg/L even for tetracycline-resistant strains of S. pneumoniae. Similar results were observed for the erythromycin- and the co-trimoxazole-Mn complex combination. In the G. mellonella infection model, mortality and morbidity rates at 96 h were significantly lower in larvae treated with [Mn(CO)₃(tpa-κ³N)]Br than phosphate buffered saline, while treatment with the tetracycline-Mn complex combination was superior to monotherapy, resulting in significantly lower mortality and morbidity rates (p ˂ 0.049).


We show that [Mn(CO)₃(tpa-κ³N)]Br has in vitro and in vivo antibacterial activity against clinically relevant strains of S. pneumoniae and has the potential to be used in combination with currently available antibiotics to increase their effectiveness against MDR S. pneumoniae.

Item Type: Article
Divisions : Faculty of Health and Medical Sciences > School of Veterinary Medicine
Authors :
Liakopoulos, Apostolos
La Ragione, Roberto
Nagel, Christoph
Schatzschneider, Ulrich
Rozen, Daniel E.
Betts, Jonathan
Date : 2020
DOI : 10.1016/j.jgar.2020.04.031
Copyright Disclaimer : © 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-ND license (
Uncontrolled Keywords : Pneumococcus; Novel antimicrobials; Tetracycline; In vitro; In vivo; Manganese
Depositing User : Clive Harris
Date Deposited : 02 Jun 2020 16:39
Last Modified : 02 Jun 2020 16:39

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800